Transcript NFP DIS - European Monitoring Centre for Drugs and Drug

The REITOX Experience
nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Lessons learned in developing a
network of National Drugs Focal
Points and challenges for the future
Alan Lodwick, Head of UK National Focal Point
and Reitox Spokesperson
Viktor Mravcik, Head of Czech National Focal Point
The REITOX Network
Réseau Européen d’Information sur les Drogues et
les Toxicomanies
n The European Information Network on Drugs and
Drug Addiction
n 1993 EMCDDA Regulation : referred to REITOX as a
“computer network” linking specialised centres
n 2006 EMCDDA Regulation: a network of Focal Points
with well defined responsibilities
n Focal Points are the “interface” between participating
countries and the Centre
National Focal Point Responsibilities
(as set out in the 2006 Regulation)
n Contribute to the establishment of key indicators and
data including guidelines
n Co-operate with experts and organisations active in
the drugs field
n Bring together experience from different sectors
n Collect and analyse all relevant information in an
objective manner at national level
n Include information on policies and solutions applied
n Provide data for the 5 Epidemiological Indicators
1993:
12 Member States
2009:
27 Member States
Norway,Croatia,Turkey
The Reitox Network Now
n 30 National Focal Points, an EC Focal Point
and Co-ordination at EMCDDA
n About 130 full-time equivalent staff in NFPs
n Diverse national arrangements for NFPs
reflecting differing national contexts
n
n
n
n
n
size
government and administrative structures
existing information systems & research tradition
culture, history and nature of drugs problem
national demands for information
n A “network of networks”
n Co-operation and support between NFPs
National Focal Point Key Relationships
EMCDDA (and EU)
5KIs, Information on Policies
and Interventions, EU Action Plan
National Government
- Policies and interventions
- Administration and funding
National Focal
Points
Parent
institution
Sub-national
Administrations
National Scientific
Community
-National experts
-Academic institutions
Specialist Agencies
e.g. public health,
statistics
Devolved responsibilities
Local
Agencies
National Focal Point Tasks
n Delivering an Annual Reporting Package:
n Standard Tables
n Structured Questionnaires
n Annual Report
n Promoting the implementation of the 5 Key
Epidemiological Indicators
n EDDRA / “Best Practice” project
n Early Warning System on New Psychoactive
Substances
n Dissemination of EMCDDA Outputs
n Within a formal annual agreement and a clear quality
framework
Reitox Achievements
n Delivering the Annual Reporting Package
n Working in partnership with EMCDDA to set out
agreed work programmes, reporting structures
& instruments and quality standards
n Providing added value at national level
n Central to monitoring of the EU Action Plan
“.. A key role in helping the EMCDDA to fulfil its mission,
both in collecting information on the drugs situation in
Europe and in helping to disseminate the EMCDDA’s
scientific outputs”
external evaluation of the EMCDDA - December 2007
Reitox Challenges
n Maintaining support and co-operation at national
level
n Encouraging collection of standardised data while
recognising national needs and differences
n Adapting to changing requirements and new
phenomena within limited resources
n Improving and rationalising outputs published
n Improving and demonstrating the quality of
information provided
n Reitox enlargement and international cooperation
The Czech Reitox NFP –
An Example of the Interaction
Between National and European Drug
Information Systems
Czech NFP – Background
n Czech Drug Policy Strategy since 1993 (fourth one in
2005-2009)
n Candidate country since 1996
n EMCDDA technical assistance projects
n Phare twinning (Austria plus other EU experts)
n Cooperation with Reitox and EMCDDA started already
before the Czech NFP was established
n
n
n
n
ESPAD, TDI register since 1995
DRDs Special Register since 1998
PDU estimates since 1999
But historical (treatment) data on illegal drugs since 1959
n EU member state since 2004 – full inclusion into
Reitox and EMCDDA structures and reporting life
Czech NFP and DIS – Structure
n Czech National Monitoring Centre for Drugs
and Drug Addiction – Reitox NFP
n Established by the Government in June 2002
within the secretariat of the Government
Council for Drug Policy Coordination
n Fully operational since January 2003
n 7-7.5 staff members
n National Action Plan for Drug Information
System - biannual
n 7 permanent task groups (5 on KI, lawenforcement data, EWS), other ad hoc groups
n Advisory Board for Drug Data Collection
Czech NFP – Tasks
n Reflects EMCDDA tasks at the EU level
n Situation analysis
n hard core – 5 harmonised KIs
n other (core) data
n Responses, policies, strategies
n Other special projects (EDDRA/Best Practice,
ELDD,EWS)
n Information Dissemination
n Annual Reports
n Bimonthly fact-sheet „Zaostřeno na drogy“
n Other publications
n www.drogy-info.cz (www.focalpoint.cz)
n Not only coordination function, but also data
production
Impact of Reitox Membership on the
Czech NFP and DIS
n Adoption of grounded and novel scientific methods,
approaches, and know-how
n Quality and standardisation of data collection and
analysis
n Quality assurance of information outputs
n Development of national Drug Information System
n Easy and fast information exchange within Reitox
network
n Participation in European/international projects
n Strengthening of scientific/expert „semi-independence“ of
NFP and DIS
n Dissemination of EMCDDA and Reitox standards to the
third countries (potential EU candidates and others)
Summary of Cooperation within Reitox
n A lot of work and duties
n Both methodological/scientific and technical/administrative
n But mutually (mostly) beneficial and appreciated
n Allowing common and concentrated actions towards
new phenomena and challenges
n Increasing common understanding of complex drug
phenomenon within Reitox members (e.g. convergence
of terminology)
n Very often interesting and inspiring (new methods,
tools, approaches, projects)
n Based on formal framework but realised in a way of
informal interpersonal relations and communication
Reitox Lessons Learnt
n True Partnership is key
n System must have the means to evolve in a
controlled way
n Need for agreed guidelines and standards
with incentives to comply
n But system needs to allow flexibility about the
way that objectives are achieved
n Recognise the need for networks within the
network
n Must serve European but also national needs
and give added value to both levels
Thanks☺
nnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
[email protected]
[email protected]
www.emcdda.europa.eu/about/partners/reitox-network
www.ukfocalpoint.org
www.drogy-info.cz (www.focalpoint.cz)